JP2024512813A5 - - Google Patents

Info

Publication number
JP2024512813A5
JP2024512813A5 JP2023561148A JP2023561148A JP2024512813A5 JP 2024512813 A5 JP2024512813 A5 JP 2024512813A5 JP 2023561148 A JP2023561148 A JP 2023561148A JP 2023561148 A JP2023561148 A JP 2023561148A JP 2024512813 A5 JP2024512813 A5 JP 2024512813A5
Authority
JP
Japan
Application number
JP2023561148A
Other languages
Japanese (ja)
Other versions
JPWO2022211574A5 (https=
JP2024512813A (ja
JP7728030B2 (ja
Filing date
Publication date
Priority claimed from KR1020220040453A external-priority patent/KR102463786B1/ko
Application filed filed Critical
Priority claimed from PCT/KR2022/004706 external-priority patent/WO2022211574A1/ko
Publication of JP2024512813A publication Critical patent/JP2024512813A/ja
Publication of JPWO2022211574A5 publication Critical patent/JPWO2022211574A5/ja
Publication of JP2024512813A5 publication Critical patent/JP2024512813A5/ja
Application granted granted Critical
Publication of JP7728030B2 publication Critical patent/JP7728030B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023561148A 2021-04-01 2022-04-01 抗老化遺伝子ｋｌｏｔｈｏの発現を誘導する化合物を含む慢性腎疾患の予防または治療用組成物 Active JP7728030B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20210042955 2021-04-01
KR10-2021-0042955 2021-04-01
KR10-2022-0040453 2022-03-31
KR1020220040453A KR102463786B1 (ko) 2021-04-01 2022-03-31 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 만성신장질환의 예방 또는 치료용 조성물
PCT/KR2022/004706 WO2022211574A1 (ko) 2021-04-01 2022-04-01 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 만성신장질환의 예방 또는 치료용 조성물

Publications (4)

Publication Number Publication Date
JP2024512813A JP2024512813A (ja) 2024-03-19
JPWO2022211574A5 JPWO2022211574A5 (https=) 2024-04-01
JP2024512813A5 true JP2024512813A5 (https=) 2024-04-01
JP7728030B2 JP7728030B2 (ja) 2025-08-22

Family

ID=83456608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023561148A Active JP7728030B2 (ja) 2021-04-01 2022-04-01 抗老化遺伝子ｋｌｏｔｈｏの発現を誘導する化合物を含む慢性腎疾患の予防または治療用組成物

Country Status (7)

Country Link
US (1) US20240216341A1 (https=)
EP (1) EP4317140A4 (https=)
JP (1) JP7728030B2 (https=)
AU (2) AU2022248891A1 (https=)
BR (1) BR112023020026A2 (https=)
CA (1) CA3213910A1 (https=)
WO (1) WO2022211574A1 (https=)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001083427A1 (en) * 2000-04-28 2001-11-08 Sankyo Company, Limited PPARη MODULATORS
US8318703B2 (en) * 2001-12-06 2012-11-27 Fibrogen, Inc. Methods for improving kidney function
EP1388341A1 (en) 2002-08-07 2004-02-11 Aventis Pharma Deutschland GmbH Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
WO2011084452A1 (en) 2009-12-16 2011-07-14 Eli Lilly And Company Therapeutic uses of soluble alpha-klotho
KR101372721B1 (ko) 2010-06-18 2014-03-14 이화여자대학교 산학협력단 Ｉｎｔｅｒｌｅｕｋｉｎ―６ 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물
US10647689B2 (en) * 2015-04-28 2020-05-12 Sanford Burnham Prebys Medical Discovery Institute Apelin receptor agonists and methods of use thereof
KR101770310B1 (ko) 2015-08-24 2017-08-24 이화여자대학교 산학협력단 2-(페닐아미노)벤조[d]옥사졸-5-올 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
KR20250097990A (ko) * 2016-11-10 2025-06-30 베링거 인겔하임 인터내셔날 게엠베하 약제학적 조성물, 치료 방법 및 이의 용도
EP3611521A1 (en) 2018-08-16 2020-02-19 General Electric Technology GmbH Apparatus for monitoring a condition of an electrical power transmisison medium
IT201900007446A1 (it) * 2019-05-29 2020-11-29 Giuseppe Castellano Composizione comprendente citrato e carnitina in grado di attivare la produzione della proteina klotho
KR20200145909A (ko) 2019-06-20 2020-12-31 주식회사 레이지소사이어티 면도날 자동주문 장치
JP7412546B2 (ja) 2019-10-02 2024-01-12 克洛索科学公司 抗老化遺伝子ｋｌｏｔｈｏの発現を誘導する化合物およびその用途
KR102375097B1 (ko) * 2021-04-01 2022-03-17 주식회사 클로소사이언스 항노화 유전자 klotho의 발현을 유도하는 화합물을 포함하는 퇴행성 신경질환의 예방 또는 치료용 조성물

Similar Documents

Publication Publication Date Title
CL2025003455A1 (es) Forma cristalina de 4-(((etil(metil)amino)metilen)amino)-2,5-dimetilbenzoato de 4-(difluorometoxi)bencilo o una de sus sales y uso como fungicida.
CL2025004013A1 (es) Uso de una combinación herbicida que comprende una isoxazolina y un éter fenílico.
CL2025004110A1 (es) Método para establecer una infraestructura de transporte eléctrico en una mina, método de extracción en una mina y un sistema de planificación para una mina.
BR202022009269U2 (https=)
JP2024512813A5 (https=)
BY13163U (https=)
BY13168U (https=)
CN307044717S (https=)
CN307044598S (https=)
CN307050259S (https=)
BY23966C1 (https=)
BY23965C1 (https=)
BY23963C1 (https=)
CN307050222S (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13158U (https=)
BY13169U (https=)
BY13159U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
BY13142U (https=)